Biovica International AB
(STU:9II)
€
0.208
-0.012 (-5.45%)
Market Cap: 21.30 Mil
Enterprise Value: 15.01 Mil
PE Ratio: 0
PB Ratio: 2.33
GF Score: 60/100 - Q2 2023 Biovica International AB Earnings Call TranscriptDec 15, 2022€0.742 (+1.50%)Earnings
- Biovica International AB Market update FDA clearance TranscriptAug 18, 2022
- Q4 2022 Biovica International AB Earnings Call TranscriptJun 16, 2022€3.15 (+2.75%)Earnings
- Biovica International AB Corporate Analyst Meeting TranscriptMay 17, 2022
- Q3 2022 Biovica International AB Earnings Call TranscriptMar 15, 2022€2.62 (+7.74%)Earnings
- Q2 2022 Biovica International AB Earnings Call TranscriptDec 01, 2021€3.68 (+0.95%)Earnings
- Q1 2022 Biovica International AB Earnings Call TranscriptSep 02, 2021€5.85 (+6.29%)Earnings
- Biovica International AB CEO's Presentation Annual General Meeting 2021 - Pre-Recorded TranscriptAug 27, 2021
- Q4 2021 Biovica International AB Earnings Call TranscriptJun 18, 2021€4.48 (-0.22%)Earnings
- Biovica International AB Capital Markets Day (Virtual) TranscriptJun 09, 2021
- Q3 2021 Biovica International AB Earnings Call TranscriptMar 18, 2021€4.05 (+7.63%)Earnings
- Q2 2021 Biovica International AB Earnings Call TranscriptDec 08, 2020Earnings
Q2 2021 Biovica International AB Earnings Call Transcript
Dec 08, 2020 / 09:00AM GMT
Operator
Ladies and gentlemen, welcome to the Biovica International teleconference Q2 2020.
(Operator Instructions)
Today, I'm pleased to present CEO, Anders Rylande. Speaker, please begin.
Anders Rylander;publ;CEO;Director
Biovica International AB
()-&
Thank you very much, Nas, and welcome, everyone, to the Biovica interim report presentation. So if you move to Slide #2, we have the names of the participant. Besides me here today, I have our Executive Vice President and CFO, Cecilia Driving, Cecilia.
Cecilia Driving;publ;CFO and Executive VP of HR;IR
Biovica International AB
()-&
Good morning, everyone.
Anders Rylander;publ;CEO;Director;Mattias Bergqvist
Biovica International AB;Biovica International AB
()-&
And also, our Clinical Development Director, Mattias Bergqvist.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)